Consensus measurement framework for community pharmacy medication review outcomes

This consensus project tells geriatric pharmacy researchers precisely which instruments and definitions to use when measuring the seven core outcomes of medication reviews in older, multimorbid, polypharmacy patients, addressing a major barrier to evidence synthesis.

medication reviewcommunity pharmacycore outcome setcore outcome measurement setEQ-5D-5LSTOPP/STARTpolypharmacypotentially inappropriate medicationsdrug-drug interactionsgeriatricsconsensus studyoutcome measurement Geriatrics / Geriatric Pharmacy

Background Information

Harmonizing outcome measures boosts medication review quality for older adults.

Standardizing outcome measurements can enhance the comparability and effectiveness of medication reviews for older adults with multimorbidity and polypharmacy. Experts selected EQ-5D-5L for Health-related Quality of Life (HRQoL) and scales for pain relief, creating criteria for overuse, underuse, and potentially inappropriate medications. The Core Outcome Measurement Set (COMS) enables comparable research and improves the quality of community pharmacist-led medication reviews, although its application may be setting-specific. Standardizing outcome measures advances the efficacy of medication reviews in older patients.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Vogt CJ, Eickhoff C, Foulon V, Hughes C, Kessler J, Paul C, Ryan C, Schulz M, Teichert M, Woltersdorf R, Wurmbach VS, Seidling HM

Citation: Vogt CJ, Eickhoff C, Foulon V, et al. Development of a Core Outcome Measurement Set for studies of community pharmacist-led medication reviews in older patients with multimorbidity and polypharmacy. International journal of clinical pharmacy. 2026. doi:10.1007/s11096-026-02223-y

Article Links: PubMed · Journal / DOI

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →